In a mouse model of colitis, treatment with Frondanol significantly reduced colonic inflammation and levels of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-6, and IL-1β, indicating its potential anti-inflammatory action in the gut lining [11]. This evidence concerns the gene TNF and colitis.